Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.19.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Diluted Net Loss Per Common Share Diluted net loss per common share for the three and nine months ended September 30, 2019 was determined as follows (in thousands, except share and per share amounts):

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Net (loss) income

$

(7,941

)

 

$

351

 

 

$

(39,252

)

 

$

(14,410

)

Dilutive effect of convertible debt

 

(1,815

)

 

 

 

 

 

 

 

 

 

Net (loss) income allocated to common shares

$

(9,756

)

 

$

351

 

 

$

(39,252

)

 

$

(14,410

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – basic

 

55,697,391

 

 

 

46,988,844

 

 

 

52,787,578

 

 

 

42,519,585

 

Dilutive effect of stock options

 

 

 

 

36,659

 

 

 

 

 

 

 

Dilutive effect of convertible debt

 

11,382,000

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – diluted

 

67,079,391

 

 

 

47,025,503

 

 

 

52,787,578

 

 

 

42,519,585

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share – diluted

$

(0.15

)

 

$

0.01

 

 

$

(0.74

)

 

$

(0.34

)

 

Summary of Antidilutive Securities Excluded from Computation of Weighted Average Common Stock Outstanding

The following potentially dilutive shares of common stock have not been included in the computation of diluted net (loss) income per share for the three and nine months ended September 30, 2019 and 2018, as the result would be anti-dilutive:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Warrants to purchase Series C-1 Preferred

 

 

 

 

14,033

 

 

 

 

 

 

14,033

 

Warrants to purchase common stock associated with Solar loan agreement

 

122,435

 

 

 

122,435

 

 

 

122,435

 

 

 

122,435

 

Warrants to purchase common stock associated with June 2016 public offering

 

4,218,750

 

 

 

4,218,750

 

 

 

4,218,750

 

 

 

4,218,750

 

Warrants to purchase common stock associated with March 2018 public offering – Series 1

 

 

 

 

13,198,075

 

 

 

 

 

 

13,198,075

 

Warrants to purchase common stock associated with March 2018 public offering – Series 2

 

7,988,175

 

 

 

7,988,175

 

 

 

7,988,175

 

 

 

7,988,175

 

Outstanding stock options

 

5,189,860

 

 

 

4,073,449

 

 

 

5,189,860

 

 

 

4,110,108

 

Outstanding restricted stock units

 

967,644

 

 

 

107,841

 

 

 

967,644

 

 

 

107,841

 

Common stock associated with 6% convertible senior notes

 

 

 

 

 

 

 

11,382,000

 

 

 

 

Total

 

18,486,864

 

 

 

29,722,758

 

 

 

29,868,864

 

 

 

29,759,417